Intracavernous Injection Therapy as Second-Line Treatment for ED After Radical Prostatectomy: A Literature Review.

Area of Science:

• Urology
• Andrology
• Sexual Medicine

Background:

• Erectile dysfunction (ED) is a common complication following radical prostatectomy.
• ED significantly impacts patients' quality of life.
• Oral phosphodiesterase type 5 inhibitors are often ineffective for post-prostatectomy ED.

Purpose of the Study:

• To review the mechanisms, efficacy, and safety of Intracavernous Injection (ICI) therapy.
• To evaluate ICI as a second-line treatment for ED post-radical prostatectomy.
• To discuss clinical outcomes, patient satisfaction, and predictors of success.

Main Methods:

• Review of clinical results, patient satisfaction, and compliance data.
• Analysis of predictors of success, including nerve-sparing surgical techniques.
• Interpretation of evidence and clinical experience regarding ICI therapy.

Main Results:

• ICI provides an immediate and effective means to regain erectile function.
• Successful outcomes are influenced by factors such as nerve-sparing procedures.
• ICI therapy demonstrates significant efficacy and safety in managing post-prostatectomy ED.

Conclusions:

• Intracavernous injection therapy is a cornerstone of penile rehabilitation after radical prostatectomy.
• ICI is an essential component of ED management for patients unresponsive to oral treatments.
• Further optimization of ICI therapy holds promise for improved patient outcomes.